Atlas Trials

Relapsed T-Cell Lymphoma

8 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed T-Cell Lymphoma

RecordFirmDate
CPI-613 in Combination With Bendamustine in Patients With Relapsed/Refractory T-Cell Non-Hodgkin Lymphoma (NCT04217317)Wake Forest University Health Sciences2020-09-16
Daratumumab Plus Gemcitabine, Dexamethasone, Cisplatin in pt R/R CD38+ PTCL-NOS, AITL and TFH (NCT04251065)Fondazione Italiana Linfomi - ETS2020-09-03
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies (NCT04191187)H. Lee Moffitt Cancer Center and Research Institute2019-12-06
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy (NCT03674411)Masonic Cancer Center, University of Minnesota2019-01-02
UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep (NCT02722668)Masonic Cancer Center, University of Minnesota2017-05-15
A Single Arm Study Evaluating the Efficacy and Safety of Pralatrexate in Subjects With Relapsed or Refractory PTCL (NCT03349333)Mundipharma (China) Pharmaceutical Co. Ltd2015-09-10
A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell Lymphoma (NCT01878708)Dana-Farber Cancer Institute2013-07-01

Track Relapsed T-Cell Lymphoma automatically

Every clearance here is in the API, with alerts when new ones post.